GlobalData estimates that 90% of GLP-1 RA drug sales will be from obesity drugs by 2033. Credit: KK Stock / Shutterstock. The obesity therapeutics market has gone from a standing start to the story of the year in biopharmaceuticals – […]
Obesity therapies and the multi-indication momentum: how industry is responding Read More »
Decentralized and hybrid clinical trials offer an interesting angle on traditional challenges relating to patient centricity. Source: Shutterstock. Reducing patient burden in clinical trials – especially for rare diseases – is a key objective for drug developers. Decentralized clinical trials
Reducing patient burden in rare disease trials: DCTs for increased patient centricity Read More »
Clinical supply chains need new solutions to become more efficient and sustainable. The pharmaceutical industry is in the midst of a digital revolution; technology investments and data-driven decision-making are constantly on the lips of business decision-makers. A recent survey of
Credit: Stock-Asso/Shutterstock. The field of central nervous system (CNS) drug development is awash with activity. Data from GlobalData’s drugs database, as of January 2025, highlights the major areas of action. Figure 1: CNS drugs currently on the market. Source: GlobalData
How CNS researchers are handling clinical trial turbulence Read More »
For pharmaceutical leaders, integrating sustainable solutions within supply chains is imperative to ensure long-term environmental and economic viability. (Photo courtesy of CINDE) The pharmaceutical world is changing. Sales of personalised therapies, for example, will skyrocket from $8 billion in 2022
Navigating the Complexities of Sustainable Specialty Pharma Supply Chains Read More »
Wide areas of the pharmaceutical industry are ripe for AI-driven enhancement, as examples from the industry’s top innovators reflect. Credit: Shutterstock. With 2025 well underway, the runaway momentum of artificial intelligence (AI) looks unstoppable. GlobalData estimates that the total AI
Revolutionary approaches to drug design: how AI is transforming life sciences Read More »
With experts united on the thesis that innovation in oncology will only accelerate, picking the right clinical partners will be critical for those hoping to stay up to speed in a rapidly changing industry. Source: Lightspring via Shutterstock. The oncology
Oncology R&D: emerging therapies and new challenges Read More »
Covid-19 pandemic has forced the pharmaceutical industry to make significant adjustments in its technological investment. Credits: PopTika/Shutterstock.com With the world facing threats from new and emerging infectious diseases, the ability to rapidly ramp up production of essential raw materials for
The clinical trial landscape is changing. What do organisers need to know to navigate potential disruption? Source: Shutterstock. As smaller, leaner organisations that must utilise resources carefully, biotechs face unique challenges as they enter clinical trials. These challenges are compounded
Overcoming the first hurdles: Navigating early phase challenges for biotechs Read More »
Deploying new innovations can help clinical trial resilience amid adversity. Credit: Gorodenkoff via Shutterstock. Clinical trials are the testing ground for new therapies. Ensuring the supply chains supporting these therapies remain robust is a critical link in the chain between
